Vietnam’s healthcare sector is accelerating its adoption of artificial intelligence, with AI increasingly being deployed across medical imaging, diagnostics, hospital management, clinical decision support and remote patient monitoring.
According to IMARC Group, Vietnam’s Artificial Intelligence in Healthcare Market reached US$1.78 million in 2025 and is projected to grow to US$22.48 million by 2034, meaning the market is forecast to increase more than twelvefold over the period.
The rapid growth reflects the relatively early stage of AI adoption within Vietnam’s healthcare system, but also demonstrates the scale of the opportunity as hospitals and healthcare providers accelerate digital transformation.
Artificial intelligence in healthcare encompasses a growing range of technologies and applications, including:
- AI-powered medical imaging and diagnostics
- Machine learning
- Natural language processing
- Clinical decision support
- Predictive healthcare analytics
- Robot-assisted surgery
- Virtual nursing assistants
- Administrative workflow automation
- Remote patient monitoring
- Clinical trial participant identification
- Personalised and precision medicine
One of the strongest drivers of growth is Vietnam’s national healthcare digital transformation programme. The Ministry of Health has identified AI as an important strategic technology capable of supporting diagnosis and treatment, hospital management, precision medicine, telemedicine and personalised healthcare.
Vietnam is already seeing AI move from experimentation towards practical clinical applications. AI technologies are being introduced into medical imaging and pathology to support disease detection, including cancer screening, while hospitals are exploring their use to improve clinical workflows and reduce pressure on healthcare professionals.
The Ministry of Health has highlighted applications including diagnostic imaging, personalised treatment planning, early warning systems, remote monitoring and clinical decision support. AI is also being applied to hospital management, operational data analysis, epidemiological forecasting and healthcare resource optimisation.
The development of a regulatory framework is becoming increasingly important as adoption accelerates. Vietnam’s Ministry of Health has emphasised that AI should support rather than replace healthcare professionals, while highlighting the need to ensure accuracy, patient safety, ethical implementation and appropriate governance as technologies enter clinical practice.
Vietnam is also building a national ecosystem around responsible healthcare AI. In January 2026, the National Health Information Center launched the Vietnam Responsible Healthcare AI Network (V-RHAIN) as part of cooperation with HealthAI. The initiative brought together government, healthcare organisations, universities, research institutions, technology companies and international organisations to support the responsible adoption of AI across the healthcare system.
The foundations for continued growth are significant. Vietnam’s wider Healthcare IT Market was worth US$1.6 billion in 2025 and is forecast to reach US$4.7 billion by 2034, while its Digital Health Market is projected to grow from US$2.84 billion to US$9.52 billion over the same period. These expanding digital ecosystems are creating the data, cloud infrastructure and connected healthcare systems required for more sophisticated AI applications.
Medical imaging is likely to remain one of the most important areas for adoption. Deep-learning algorithms can analyse X-rays, CT scans, MRI images and pathology slides, helping clinicians identify abnormalities and potentially improving the speed and consistency of diagnosis.
AI also has significant potential in precision medicine. By analysing clinical records alongside genomic, laboratory and imaging data, AI systems can help identify disease patterns, predict treatment responses and support more personalised therapeutic strategies.
Pharmaceutical research represents another major opportunity. AI is increasingly being used internationally for drug discovery, biomarker identification, clinical trial design and patient recruitment. As Vietnam develops its pharmaceutical, biotechnology and clinical research industries, these applications could become an increasingly important part of the country’s life sciences ecosystem.
Remote healthcare provides further potential. AI-enabled monitoring platforms can analyse data from wearable and connected medical devices to identify changes in a patient’s condition, helping clinicians manage chronic diseases and intervene earlier when problems emerge. For Vietnam, these technologies could also support improved access to specialist healthcare outside major urban centres.
The market’s 32.52% projected annual growth significantly exceeds that of Vietnam’s wider Healthcare IT and Digital Health markets, demonstrating the speed at which AI is expected to become embedded within the country’s healthcare technology infrastructure.
The opportunity extends across hospitals, laboratories, pharmaceutical companies, biotechnology businesses, medical device manufacturers and research institutions. Demand is expected to grow for AI software, computing infrastructure, cloud platforms, clinical data solutions, imaging technologies and specialist implementation services.
As Vietnam continues to modernise its healthcare system, artificial intelligence is moving from an emerging technology towards an important component of future healthcare delivery. For healthcare technology companies, AI developers, medical device manufacturers, pharmaceutical organisations and digital health innovators, Vietnam represents a small today but exceptionally fast-growing market with significant long-term potential.